VEGF-R2 ELISA Kit

Catalog No. ABIN1112706

Product Details

Target: VEGF-R2

Reactivity: Human

Detection Method: Colorimetric

Method Type: Sandwich ELISA

Detection Range: 30-800 pg/mL

Minimum Detection Limit: 30 pg/mL

Application: ELISA

Purpose: For quantitative detection of VEGFR2 in Human serum, plasma, urine, cell culture supernatant or tissue samples.

Sample Type: Serum, Plasma, Urine, Tissue Samples, Cell Culture Supernatant

Analytical Method: Quantitative

Components: 1. One 96-well plate pre-coated with anti-human VEGFR2 antibody 2. Standard: 0.5ml (900pg /mL) 3. Standard diluent buffer: 1.5 ml 4. Wash buffer (30x): 20 ml.

Material not included: 1. 37 °C incubator 2. Microplate reader (wavelength: 450nm) 3. Precise pipette and disposable pipette tips 4. Automated plate washer 5. ELISA shaker 6. 1.5ml of Eppendorf tubes 7. Plate cover 8. Absorbent filter papers 9. Plastic or glass container with volume of above 1L

Application Details

Comment:

This kit was based on standard sandwich enzyme-linked immune-sorbent assay technology. The purified anti-VEGFR2 antibody was pre-coated onto 96-well plates. And the HRP conjugated anti-VEGFR2 antibody was used as detection antibodies. The standards test samples and HRP conjugated detection antibody were added to the wells subsequently mixed and incubated then unbound conjugates were washed away with wash buffer. TMB substrates (A & B) were used to visualize HRP enzymatic reaction. TMB was catalyzed by HRP to produce a blue color product that changed into yellow after adding acidic stop solution. The density of yellow is proportional to the VEGFR2 amount of sample captured in plate. Read the O.D. absorbance at 450nm in a microplate reader and then the concentration of VEGFR2 can be calculated.

Plate: Pre-coated

Reagent Preparation:

1. Before the experiment, centrifuge each kit component for several minutes to bring down all reagents to the bottom of tubes. 2. It is recommend to measure each standard and sample in duplicate. 3. Do NOT let the plate completely dry at any time! Since the dry condition can inactivate the biological material on the plate. 4. Do not reuse pipette tips and tubes to avoid cross contamination. 5. Do not use the expired components and the components from different batches. 6. To avoid the marginal effect of plate incubation for temperature differences (the marginal wells always get stronger reaction), it is recommend to equilibrate the ABC working solution and TMB substrate for at least 30 min at room temperature (37°C ) before adding to wells.The TMB substrate (Kit Component 8) is colorless and transparent before use, if not, please contact us for replacement.

Sample Preparation:

Preparation of sample and reagents 1. Sample Isolate the test samples soon after collecting, then, analyze immediately (within 2 hours). Or aliquot and store at -20 °C for long term. Avoid multiple freeze-thaw cycles. Serum: Coagulate at room temperature for 10-20 °C min, then, centrifuge at the speed of 2000-3000 r.p.m. for 20 min to collect supernatant. If precipitation appeared, centrifuge again. Plasma: Collect plasma using EDTAor citrate plasma as an anticoagulant, and mix for 10-20 °C min, centrifuge at the speed of 2000-3000 r.p.m. for 20 min of collection. If precipitation appeared, centrifuge again. Urine: Collect urine using a sterile container, centrifuge at the speed of 2000-3000 r.p.m. for 20 min to collect supernatant. If precipitation appeared, centrifuge again. For collection of hydrothorax and cerebrospinal fluid, take reference to this operation. Cell culture supernatant: For secretory components: use a sterile container to collect. Centrifuge at the speed of 2000-3000 r.p.m. for 20 min to collect supernatant. For intracellular components: Dilute cell suspension with PBS(pH7.2-7.4) to make the cell concentration reached 1 million / ml. Damage cells and release of intracellular components through repeated freeze-thaw cycles. Centrifuge at the speed of 2000-3000 r.p.m. For 20 min to collect supernatant. If precipitation appeared, centrifuge again. Tissue samples: Cut samples and weight, add certain volume of PBS (pH7.4), rapidly frozen with liquid nitrogen. After melting, store samples at 2-8℃ . Add certain volume of PBS (pH7.4), homogenize thoroughly, centrifuge at the speed of 2000-3000 r.p.m. for 20 min to collect supernatant. Note: 1. Coagulate blood samples completely, then, centrifuge, and avoid hemolysis and particle. 2. NaN 3 cannot be used as test sample preservative, since it is the inhibitor for HRP. 3. After collecting samples, analyze immediately or aliquot and store frozen at -20 °C. Avoid repeated freeze-thaw cycles. 2. Wash buffer Dilute concentrated Wash buffer (Kit Component 4) 30-fold (1:30) with distilled water (i.e. add 20 ml of concentrated wash buffer into 580 ml of distilled water). 3. Standard Reconstitution of the Lyophilized Human VEGFR2 standard (Kit Component 2): standard solution should be prepared no more than 2 hours prior to the experiment. Two tubes of standard are included in each kit. Use one tube for each experiment. (Note: Do not dilute the standard directly in the plate) a. 800pg/ml of standard solution: Add 0.5 ml of the 800pg/ml Standard (Kit Component 2) into 0.125ml Standard diluent buffer (Kit Component 3) and mix thoroughly. b. 400 pg/ml -> 50 pg/ml of standard solutions: Label 4 Eppendorf tubes with 400pg/ml, 200 pg/ml, 100pg/ml, 50 pg/ml, respectively. Aliquot 0.2 ml of the Standard diluent buffer (Kit Component 3) into each tube. Add 0.2 ml of the above 800 pg/ml standard solution into 1st tube and mix thoroughly. Transfer 0.2 ml from 1st tube to 2nd tube and mix thoroughly. Transfer 0.2 ml from 2nd tube to 3rd tube and mix thoroughly, and so on. Chongqing Biospes Co., Ltd Product Manual

Restrictions: For Research Use only

Handling

Preservative: Sodium azide, Thimerosal (Merthiolate)

Target Details

Target: VEGF-R2

Background: VEGF receptors are receptors for vascular endothelial growth factor (VEGF). They play an essential role in the regulation of angiogenesis, vascular development, vascular permeability, and embryonic hematopoiesis.There are three main subtypes of VEGFR, numbered 1, 2 and 3. VEGFR2, also known as Kinase insert domain receptor (KDR) or Flk1 (Fetal Liver Kinase 1), plays an important role as negative regulator of VEGFA- and VEGFC- mediated lymphangiogenesis by limiting the amount of free VEGFA and/or VEGFC and preventing their binding to FLT4. Furthermore, therapeutic inhibition of VEGFR-2 action is now having an impact in the clinic for the treatment of a number of diseases.